Skip to content
healthcare.dev

Giapreza

NDC 68547-005, angiotensin II, injection, from La Jolla Pharmaceutical Company.

Product NDC
68547-005
Status
Listed
Labeler
La Jolla Pharmaceutical Company
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209360
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68547-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANGIOTENSIN II.5 mg/mL

Pharmacologic classes

Vasoconstriction [PE]; Vasoconstrictor [EPC]

Package NDCNDC-11Package
68547-005-01685470005011 VIAL, SINGLE-DOSE in 1 CARTON (68547-005-01) / 1 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c265d69a-3efe-4107-9a9e-e6fd3d531c48

Use it

Look up 68547-005 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68547-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68547-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.